2-166198713-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001365536.1(SCN9A):c.5926A>G(p.Lys1976Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000497 in 1,609,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN9A | NM_001365536.1 | c.5926A>G | p.Lys1976Glu | missense_variant | Exon 27 of 27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN9A | ENST00000642356.2 | c.5926A>G | p.Lys1976Glu | missense_variant | Exon 27 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
SCN9A | ENST00000303354.11 | c.5926A>G | p.Lys1976Glu | missense_variant | Exon 27 of 27 | 5 | ENSP00000304748.7 | |||
SCN9A | ENST00000409672.5 | c.5893A>G | p.Lys1965Glu | missense_variant | Exon 27 of 27 | 5 | ENSP00000386306.1 | |||
SCN9A | ENST00000645907.1 | c.5893A>G | p.Lys1965Glu | missense_variant | Exon 27 of 27 | ENSP00000495983.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 244900Hom.: 0 AF XY: 0.00000754 AC XY: 1AN XY: 132648
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1457702Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 724666
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.5893A>G (p.K1965E) alteration is located in exon 27 (coding exon 26) of the SCN9A gene. This alteration results from a A to G substitution at nucleotide position 5893, causing the lysine (K) at amino acid position 1965 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
This sequence change replaces lysine with glutamic acid at codon 1965 of the SCN9A protein (p.Lys1965Glu). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and glutamic acid. In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, Align-GVGD) both suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a SCN9A-related disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at